This site is intended for healthcare professionals

Updated results from phase 1b/II (EV-103) trial of Padcev with pembrolizumab for first-line treatment for advanced urothelial cancer. Seattle Genetics + Astellas

Read time: 2 mins
Published:21st Feb 2012
Condition: Bladder Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest